Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease

Background: Dry Eye Disease (DED) is a multifactorial and complex disease of the ocular surface, with a high prevalence in adults. Aims and Objectives: To compare the efficacy of 2% topical Rebamipide and 0.1% topical Sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry...

Full description

Bibliographic Details
Main Authors: Priyanka V Gandhi, Omkar Telang, Vrunda Morepatil
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Clinical Ophthalmology and Research
Subjects:
Online Access:http://www.jcor.in/article.asp?issn=2320-3897;year=2021;volume=9;issue=2;spage=55;epage=58;aulast=Gandhi
_version_ 1818726197594423296
author Priyanka V Gandhi
Omkar Telang
Vrunda Morepatil
author_facet Priyanka V Gandhi
Omkar Telang
Vrunda Morepatil
author_sort Priyanka V Gandhi
collection DOAJ
description Background: Dry Eye Disease (DED) is a multifactorial and complex disease of the ocular surface, with a high prevalence in adults. Aims and Objectives: To compare the efficacy of 2% topical Rebamipide and 0.1% topical Sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease (DED). Materials and Methods: This prospective, randomised, comparative, interventional study was conducted at a tertiary level academic centre on 240 eyes of 120 patients having DED, with Schirmer's test (without anesthesia) value less than or equal to 10mm and tear film breakup time (TBUT) less than or equal to 10 secs. After detailed ophthalmic examination, patients were randomly allocated in 4 different groups (A B C D). Group A were given 2% topical Rebamipide, group B received 2% topical Rebamipide with 0.05% topical Cyclosporine, group C were started on 0.1% topical Sodium Hyaluronate and group D were given 0.1% topical Sodium Hyaluronate with 0.05% cyclosporine. Each of these drops was given for 4 times a day for a period of 12 weeks. All patients were followed up after 2 weeks, 4 weeks and 12 weeks. Results: Out of 120 patients, 79 (65.83%) were female and 41 (34.16%) were male. The change in the mean schirmer's score and mean TBUT score was statistically significant in all four groups from baseline to 12 weeks (p<0.05). On comparing with each other, no significance difference was noted in any group. Conclusion: According to our study, 3 months of treatment with either 2% topical Rebamipide or 0.1% sodium hyaluronate is equally effective for DED and addition of 0.05% cyclosporine have no adjunctive role.
first_indexed 2024-12-17T21:54:23Z
format Article
id doaj.art-af8cf9778cf145eaa15e260d22ffd0b1
institution Directory Open Access Journal
issn 2320-3897
language English
last_indexed 2024-12-17T21:54:23Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Clinical Ophthalmology and Research
spelling doaj.art-af8cf9778cf145eaa15e260d22ffd0b12022-12-21T21:31:09ZengWolters Kluwer Medknow PublicationsJournal of Clinical Ophthalmology and Research2320-38972021-01-0192555810.4103/jcor.jcor_50_19Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye diseasePriyanka V GandhiOmkar TelangVrunda MorepatilBackground: Dry Eye Disease (DED) is a multifactorial and complex disease of the ocular surface, with a high prevalence in adults. Aims and Objectives: To compare the efficacy of 2% topical Rebamipide and 0.1% topical Sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease (DED). Materials and Methods: This prospective, randomised, comparative, interventional study was conducted at a tertiary level academic centre on 240 eyes of 120 patients having DED, with Schirmer's test (without anesthesia) value less than or equal to 10mm and tear film breakup time (TBUT) less than or equal to 10 secs. After detailed ophthalmic examination, patients were randomly allocated in 4 different groups (A B C D). Group A were given 2% topical Rebamipide, group B received 2% topical Rebamipide with 0.05% topical Cyclosporine, group C were started on 0.1% topical Sodium Hyaluronate and group D were given 0.1% topical Sodium Hyaluronate with 0.05% cyclosporine. Each of these drops was given for 4 times a day for a period of 12 weeks. All patients were followed up after 2 weeks, 4 weeks and 12 weeks. Results: Out of 120 patients, 79 (65.83%) were female and 41 (34.16%) were male. The change in the mean schirmer's score and mean TBUT score was statistically significant in all four groups from baseline to 12 weeks (p<0.05). On comparing with each other, no significance difference was noted in any group. Conclusion: According to our study, 3 months of treatment with either 2% topical Rebamipide or 0.1% sodium hyaluronate is equally effective for DED and addition of 0.05% cyclosporine have no adjunctive role.http://www.jcor.in/article.asp?issn=2320-3897;year=2021;volume=9;issue=2;spage=55;epage=58;aulast=Gandhiconjunctival impression cytologycyclosporinerebamipidesodium hyaluronate
spellingShingle Priyanka V Gandhi
Omkar Telang
Vrunda Morepatil
Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
Journal of Clinical Ophthalmology and Research
conjunctival impression cytology
cyclosporine
rebamipide
sodium hyaluronate
title Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
title_full Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
title_fullStr Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
title_full_unstemmed Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
title_short Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
title_sort comparing the efficacy of 2 topical rebamipide and 0 1 topical sodium hyaluronate with or without 0 05 topical cyclosporine in patients with dry eye disease
topic conjunctival impression cytology
cyclosporine
rebamipide
sodium hyaluronate
url http://www.jcor.in/article.asp?issn=2320-3897;year=2021;volume=9;issue=2;spage=55;epage=58;aulast=Gandhi
work_keys_str_mv AT priyankavgandhi comparingtheefficacyof2topicalrebamipideand01topicalsodiumhyaluronatewithorwithout005topicalcyclosporineinpatientswithdryeyedisease
AT omkartelang comparingtheefficacyof2topicalrebamipideand01topicalsodiumhyaluronatewithorwithout005topicalcyclosporineinpatientswithdryeyedisease
AT vrundamorepatil comparingtheefficacyof2topicalrebamipideand01topicalsodiumhyaluronatewithorwithout005topicalcyclosporineinpatientswithdryeyedisease